The purpose of this paper is to investigate the qualitative behavior of HIV dynamics models with immune impairment. The HIV particles infect both CD4 + T cells and macrophages. Both latently and actively infected cells are incorporated into the models. The models consider multiple discrete or distributed delays to characterize the time between an HIV contact of an uninfected target cell and the creation of mature HIV. The existence and global stability of the steady states are determined by the basic reproduction number. The global stability analysis of the steady states is performed using Lyapunov method. We solve the system of delay differential equations numerically to support the theoretical results.
Introduction
In order to understand the Human Immunodeficiency Virus (HIV) dynamics within-host and the drug therapy strategies, many mathematical models have been constructed and developed (see ). Some of these models assume that HIV infects one category of target cells, that is, CD4 + T cells [1, 29, 40] . Among these models, the basic model which has been developed by Nowak and Bangham [1] is considered the most popular. The model is a three-dimensional system of ODEs which characterize the interaction between HIV (v), uninfected CD4 + T cells (x), and infected CD4 + T cells (u). Other HIV dynamics models assume that HIV has categories of target cells, CD4 + T cells and macrophages [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] .
The basic model describing the HIV interaction with two categories of target cells is presented in [30] and [32] as:
x 2 (t) = λ 2 -d 2 x 2 (t) -β 2 x 2 (t)v(t),
u 2 (t) = β 2 x 2 (t)v(t) -μ 2 u 2 (t),
v(t) = k 1 u 1 (t) + k 2 u 2 (t) -rv(t).
The variables describe the concentrations of x i , the uninfected and infected cells and free HIV, respectively; i = 1 and i = 2 represent the CD4 + T cells and macrophages, respectively; λ i represents the generation rate of the uninfected cells; d i are the death rate constants; and β i are the infection rate constants. Equations (2) and (4) represent the population dynamics of the activated infected cells and show that they die with the same constant rate μ i . The HIV particles are generated from infected CD4 + T cells and infected macrophages at rates k 1 u 1 and k 2 u 2 , respectively. The HIV particles are cleared at rate rv. A lot of considerations have been added that aim to get the best representation of the HIV infection. Most notable are latent HIV reservoirs which serve as a major barrier in curing HIV infection. Despite the fact that the antiretroviral therapy significantly limits the level of HIV in the blood, there is still a low viral load due to ongoing reactivation of latent infected cells reservoirs. Variant models have been developed to study the dynamics of HIV in the presence of latent reservoirs (see, e.g., [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] ).
Cytotoxic T Lymphocyte (CTL) cells play a prominent role in achieving the best representation of the HIV dynamics. CTL cells attack the HIV infected cells and hence try to eliminate or control the infection. The first mathematical model describing the interaction between CTL immune response and viral infection had been presented by Nowak and Bangham [1] , since then many mathematical models have been presented to study the effect of CTL immune response on virus dynamics (see, e.g., [41] [42] [43] [44] ). However, it has been reported in [45] that during the infection, HIV causes an impairment in the CTL job. Virus dynamics models with CTL immune impairment have been studied in many papers (see, e.g., [45] [46] [47] [48] [49] [50] [51] [52] ). All the HIV dynamics models with CTL immune impairment presented in the literature consider one category of target cells, CD4 + T cells.
In the present paper we investigate the global stability of an HIV dynamics model with CTL immune impairment and two categories of target cells, CD4 + T cells and macrophages. The importance of considering such a model is due to the observation of Perleson el al. that after the rapid first phase of decay during the initial 1-2 weeks of an antiretroviral treatment, plasma virus levels declined at a considerably slower rate [31] . This second phase of viral decay was attributed to the turnover of a longer-lived virus reservoir of infected cell population. Therefore, the two target cells model is more accurate than the one target cell model, and then more accurate drug efficacy is determined when using the model with two classes of target cells. Moreover, a better understanding of the mechanisms behind this immune impairment in HIV infection may help to devise better therapeutic regimens and to identify patients more responsive to certain drugs [53] . We consider both latently and actively infected cells. We incorporate multiple discrete or distributed time delays to describe the time between the HIV contacts of target cells and the emission of new mature HIV particles. We study global stability of the two steady states of the model using Lyapunov method. The theoretical results are supported by numerical simulations.
HIV model with discrete delays
We study the following HIV model:
Here u i , y i and z are the concentrations of the latent infected, actively infected and CTL cells, respectively. The fractions ρ i and 1 -ρ i with 0 < ρ i < 1 where i = 1, 2 are the probabilities that upon infection, uninfected cell will become either latently or actively infected. Equations (7) and (10) To ensure the uniqueness of the solution of system (6)-(13), we take the following initial conditions [54] :
where
, C is the Banach space of continuous functions mapping the interval [-κ, 0] into R ≥0 .
Nonnegativity and boundedness

Proposition 1
The solutions of system (6)-(13) are nonnegative and ultimately bounded.
Proof From Eqs. (6)-(13) of the system, we have
From Eqs. (6) and (9), we have sup
. Let us define 
Steady states
The basic reproduction number of system (6)- (13) is given as:
Lemma 1 For system (6)- (13) Proof The steady states of model (6)- (13) satisfy
One solution of Eqs. 
where 
Global stability
We use Lyapunov method to investigate the global stability of the steady states. Let
. (13) is globally asymptotically stable.
It is seen that (6)- (13), we obtaiṅ
Equation (23) can be simplified aṡ
It follows thatẆ 1 ≤ 0 if R 0 ≤ 1. Therefore,Ẇ 1 = 0 implies that x i = x 0 i , v = 0 and z = 0. One can easily show that the largest invariant set Ω 0 ⊆ Ω = {(x 1 , y 1 , u 1 , x 2 , y 2 , u 2 , v, z)|Ẇ 1 = 0} is the singleton {E 0 }. By LaSalle's invariance principle, E 0 is globally asymptotically stable.
Theorem 2 If R 0 > 1, then E
* for system (6)- (13) is globally asymptotically stable.
CalculatingẆ 2 along system (6)- (13), we obtaiṅ
Using the following chronic steady state conditions:
we can simplify:
Due to steady state conditions, we can rewritė
Consider the following relations:
Using similar relations for the terms containing τ 3 and τ 4 , we finally obtaiṅ
It follows thatẆ 2 ≤ 0. Now LaSalle's invariance principle implies that E * is globally asymptotically stable.
HIV model with distributed delays
We study the HIV infection model with distributed time delays:
The and g(τ ) > 0, as well as
Then 0 < H j ≤ 1 and 0 < G ≤ 1,j = 1, . . . , 4. The initial conditions for system (25)- (32) are the same as given by (14) where κ = max{s 1 , s 2 , s 3 , s 4 , s 5 }.
Nonnegativity and boundedness
Proposition 2 The solutions of system (25)-(32) are nonnegative and ultimately bounded.
Proof The nonnegativity can be shown as in Proposition 1. To show the boundedness, let us define 
Steady states
The basic reproduction number R 0 for system (25) - (32) is as follows:
We find that system (25)- (32) 
. In addition, from Eqs. (33)- (40) we get
Global stability
Theorem 3 If R 0 ≤ 1, then E 0 for system (25) - (32) is globally asymptotically stable.
Proof Define
CalculatingV 1 along system (25)- (32), we obtaiṅ
Similar to the proof of Theorem 1, E 0 is globally asymptotically stable if R 0 ≤ 1.
Theorem 4
If R 0 > 1, then E * for system (25) - (32) is globally asymptotically stable.
It is seen that function V 2 is positive definite. The time derivative of V 2 is given by the following:
Using chronic steady state conditions
The following relations will be used:
Now using the last relations with steady state conditions and Eq. (42), we can rewritė
Finally, we obtaiṅ
Applying LaSalle's invariance principle to the last equation, we getV 2 ≤ 0, leading to the global asymptotic stability of the chronic steady state E * .
Numerical simulations
In this section, we perform numerical simulation for model (6)- (13) with values of the parameters given in Table 1 From the above, one can see that the infection rate parameters β 1 and β 2 have significant effects on stabilizing the infection-free steady state. This is because R 0 can be decreased by decreasing the values of β 1 and β 2 . The values of the parameters β 1 and β 2 can be reduced when an HIV infected patient is treated by reverse transcriptase inhibitor (RTI) drugs which prevent HIV from infecting the uninfected target cells. When incorporating the RTI drugs into the HIV dynamics model, the parameters β 1 and β 2 will be replaced by (1 -)β 1 and (1 -)β 2 , respectively, where is the drug efficacy with 0 ≤ < 1. In this case, the basic reproduction number is given by
Therefore, one can find the minimum drug efficacy m , which makes R 0 ( ) ≤ 1 and then stabilizes the system around the infection-free steady state E 0 , as:
Case II. Effect of the time delay on the HIV dynamics In this case, we fix the parameters β 1 = 0.002, β 2 = 0.001 and ρ 1 = ρ 2 = 0.5. We consider initial conditions IC1. Figure 2 shows that the stability of the steady states has been changed by changing the values of the delay parameter τ c . It can be seen that as τ c is increased the concentration of the uninfected cells is increased, while the concentrations of infected cells, free HIV particles and CTLs are decreased. From Fig. 2 we can see that, in case of smaller values of τ c , trajectories of the system will converge to E * . If the value of τ c is increased, trajectories will converge to E * and finally approach E 0 . Using the values of the parameters given in Table 1 , we have the following: (i) if 0.0 ≤ τ c < 1.0932, then E * exists and is globally asymptotically stable;
(ii) if τ c ≥ 1.0932, then E 0 is globally asymptotically stable. This result support the results of Theorems 1 and 2. From a biological point of view, the intracellular delay plays a similar role as an antiviral treatment in eliminating the virus. We observe that sufficiently large delay suppresses viral of virus that escapes treatment [18] . Subsequently, after activation of the latently infected cells, new HIV will be produced and released into the blood stream [55] . From Fig. 4 we can see that, when ρ c is increased, the concentrations of uninfected cells, actively infected 
Conclusion and discussion
All of the existing mathematical models of HIV infection with CTL immune impairment study the HIV infection and production in one class of target cells, CD4 + T cells. However, it has been reported in several papers that HIV can infect both CD4 + T cells and macrophages. In this paper, we have studied an HIV dynamics model with CTL immune impairment and with two classes of target cells, CD4 + T cells and macrophages. We have considered two types of infected cells, latently infected cells (such cells contain HIV but are not producing it) and actively infected cells (such cells are producing HIV). The model considers multiple discrete or distributed time delays to characterize the time between an HIV contact of an uninfected target cell and the creation of mature HIV particles. We have shown that the solutions of the model are nonnegative and ultimately bounded which ensures the well-posedness of the model. We have derived a biological threshold number R 0 (the basic reproduction number) which fully determines the existence and stability of the two steady states of the model. We have investigated the global stability of the model steady states by using Lyapunov method and LaSalle's invariance principle. We have proven that (i) if R 0 ≤ 1, then the infection-free steady state E 0 is globally asymptotically stable and HIV is predicted to be completely cleared from the HIV infected individuals, (ii) if R 0 > 1, then the chronic steady state E * is globally asymptotically stable and a chronic HIV infection is attained. We have conducted numerical simulations and have shown that both the theoretical and numerical results are consistent. Our analysis extends the results presented in [49] , where the global stability was analyzed for a model with one target cell population. When we consider the HIV dynamics with only one class of target cells, CD4 + T cells, then model (6)-(13) under the effect of RTI drug therapy with drug efficacy leads to the following model:
y 1 (t) = (1 -)ρ 1 β 1 e -α 1 τ 1 x 1 (t -τ 1 )v(t -τ 1 ) -ay 1 (t) -δy 1 (t),
u 1 (t) = (1 -)(1 -ρ 1 )β 1 e -α 2 τ 2 x 1 (t -τ 2 )v(t -τ 2 ) + δy 1 (t) -pu 1 (t)z(t) -μu 1 (t),
z(t) = cu 1 (t) -mu 1 (t)z(t) -bz(t).
The basic reproduction number for system (44)- (48) 
Comparing Eqs. (43) and (49), we get that (44)- (48) is globally asymptotically stable; however, R 0 ( ) > 1 and so E 0 of (6)- (13) is unstable. Therefore, more accurate drug efficacy is determined when using the model with two classes of target cells. This shows the importance of considering the effect of the macrophages in the HIV dynamics.
In the literature, fractional-order differential equations have been applied with the purpose of obtaining a deeper understanding of the complex behavioral patterns of HIV dynamical systems [53, [55] [56] [57] . The memory property of the fractional models allows the integration of more information from the past, which translates into more accurate predictions for the model. Clinicians can thus use the information (in terms of behavior predictions) of fractional-order systems to fit patients' data with the most appropriate noninteger-order index [53] . As a future work it is reasonable to use a corresponding fractional modification of our models, as fractional differential equations inherently include memory.
